Literature DB >> 6802893

Methacholine bronchial challenge in children.

G G Shapiro, C T Furukawa, W E Pierson, C W Bierman.   

Abstract

Methacholine sensitivity was evaluated in 166 young subjects who had normal resting spirometric values but who presented problems suggesting lower airways hyperreactivity. Fifty-eight patients (35%) did not have significant sensitivity. The diagnosis of asthma was excluded in this subgroup. Forty-one patients (25%) had mild methacholine sensitivity, 49 (30%) had moderate sensitivity, and 18 (11%) had extreme methacholine sensitivity. Many patients who reacted had chief complaints of cough, bronchitis, or other low respiratory-tract symptoms and did not complain of wheezing. Methacholine challenge helped to clarify appropriate therapy in these individuals. One-year follow-up of these patients showed most patients to be continuing the therapeutic regimen that had been prescribed initially. Methacholine bronchoprovocation was a useful adjunct to management of this large outpatient population of children and young adults and deserves attention as a procedure relevant to patients care, not solely as an investigational test.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802893     DOI: 10.1016/0091-6749(82)90147-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  4 in total

Review 1.  Clinical expression of bronchial hyperreactivity in children.

Authors:  C W Bierman; G G Shapiro
Journal:  Clin Rev Allergy       Date:  1989

2.  Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate.

Authors:  P Mahachoklertwattana; K Sudkronrayudh; C Direkwattanachai; L Choubtum; C Okascharoen
Journal:  Arch Dis Child       Date:  2004-11       Impact factor: 3.791

3.  Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33.

Authors:  Christina A Christianson; Nicholas P Goplen; Iram Zafar; Chaoyu Irvin; James T Good; Donald R Rollins; Balachandra Gorentla; Weimin Liu; Magdalena M Gorska; HongWei Chu; Richard J Martin; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2015-01-21       Impact factor: 10.793

4.  Protective effect by UCB JO28 against histamine and methacholine induced bronchial hyperreactivity.

Authors:  F P Maesen; J J Smeets; E Baltes; J P Rihoux
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.